Interferons in the treatment of human papillomavirus diseases
- 1 January 1986
- journal article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 5 (2) , 139-165
- https://doi.org/10.1007/bf00046428
Abstract
A variety of epithelioproliferative benign neoplasms, both trivial and life-threatening, are caused by subtypes of human papillomaviruses. Interferons objectively regress HPV-induced warty disease and affect the regrowth of the transformed epithelium. Interferons effectively control the most serious and potentially life-threatening papillomavirus associated diseases, respiratory papillomatosis and genital warts, but not without the anticipated side effects associated with this potent biological weapon. It is entirely possible and even likely that individual species of interferons act preferentially on certain cells, tissues or organs in response to particular viruses. Combined therapies, such as surgery in combination with interferon, or podophyllin in conjunction with interferon alfa-nl, may prove most efficacious.Keywords
This publication has 47 references indexed in Scilit:
- Efficacy of Human Lymphoblastoid Interferon in the Therapy of Resistant Condyloma AcuminataObstetrics & Gynecology, 1986
- Analysis of antibody response in patients receiving recombinant Escherichia coli-derived human interferon-gammaClinical Immunology and Immunopathology, 1985
- Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferonJournal of the American Academy of Dermatology, 1984
- Human Papillomavirus Type 16 and Early Cervical NeoplasiaNew England Journal of Medicine, 1984
- Laryngeal Papillomavirus Infection during Clinical RemissionNew England Journal of Medicine, 1983
- Systemic Interferon Alpha Treatment of Human Condylomata AcuminataActa Obstetricia et Gynecologica Scandinavica, 1983
- Comparison of the Antiviral Activities of Various Cloned Human Interferon- Subtypes in Mammalian Cell CulturesJournal of General Virology, 1981
- APPLICATION OF HUMAN LEUCOCYTE INTERFERON IN PATIENTS WITH CARCINOMA OF THE UTERINE CERVIXThe Lancet, 1981
- Human leukocyte interferon produced by E. coli is biologically activeNature, 1980
- Synthesis in E. coli of a polypeptide with human leukocyte interferon activityNature, 1980